Drug Discovery company. Developing novel molecules for the treatment of obesity.
| Website | https://eolo-pharma.com/ |
| Revenue | $2 million |
| Employees | 15 (4 on RocketReach) |
| Founded | 2017 |
| Address | Sutter St, San Francisco, California, US |
| Technologies |
JavaScript
,
HTML
,
PHP
+5 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Drug Stores & Pharmacies, Drug Discovery, Retail, Pharmaceuticals |
| Competitors | Galderma, Actavis plc (now Allergan), Medytox, Revance, Ipsen, Hugel Inc., Sientra, Inc., Evolus +28 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular EOLO PHARMA employee's phone or email?
The EOLO PHARMA annual revenue was $2 million in 2026.
María Garat is the CEO of EOLO PHARMA.
4 people are employed at EOLO PHARMA.
EOLO PHARMA is based in San Francisco, California.
The NAICS codes for EOLO PHARMA are [3254, 325, 32541, 32].
The SIC codes for EOLO PHARMA are [283, 28].